Gliclazide + Metformin Tablets(Er)

Form: Tablets(ER)

Strength: Gliclazide 30 mg/60 mg + Metformin 500/1000 mg

Reference Brands: Glizid-M XR(US & EU)

Category: Diabetes

Gliclazide + Metformin Extended-Release (ER) tablets are not FDA-approved in the United States but are widely authorized and marketed in the European Union under national procedures. The combination is indicated for managing type 2 diabetes mellitus in adults inadequately controlled on monotherapy. Products are registered under well-known brands like Diamicron MR + Metformin XR. European regulatory agencies mandate bioequivalence, stability, and pharmacodynamic evidence to ensure safety and efficacy. Although not listed in the U.S. Orange Book, this fixed-dose combination supports enhanced patient compliance and glycemic control. For sourcing support and B2B pharmaceutical trade, visit Pharmatradz.com.